Phorbol ester-stimulated phosphorylation of PU.1: Association with leukemic cell growth inhibition

被引:58
作者
Carey, JO
Posekany, KJ
deVente, JE
Pettit, GR
Ways, DK
机构
[1] E CAROLINA UNIV, SCH MED, DEPT MED, SECT ENDOCRINOL & METAB, GREENVILLE, NC 27858 USA
[2] E CAROLINA UNIV, SCH MED, DEPT MICROBIOL IMMUNOL, GREENVILLE, NC 27858 USA
[3] ARIZONA STATE UNIV, CANC RES INST, TEMPE, AZ 85287 USA
关键词
D O I
10.1182/blood.V87.10.4316.bloodjournal87104316
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PU.1, a member of the ets transcription factor family, has been previously shown to be necessary for tetradecanoylphorbol-13 acetate (TPA)-induced U937 leukemic cell maturation. We examined the effects of TPA on PU.1 content and PU.1 DNA binding activity in U937 cells. Unstimulated cells expressed PU.1 mRNA transcripts and TPA did not increase these levels. However, TPA treatment induced phosphorylation of PU.1. Gel-shift analysis using a labeled PU.1 oligomer showed that TPA induced a unique PU.1 binding activity. This binding activity was phosphorylation-dependent, as indicated by the ability of phosphatase treatment to abolish its detection. The PU.1 binding activity was generated at TPA-13 concentrations stimulating growth arrest and was blocked by the PKC inhibitor GF109203X, which antagonized TPA-induced growth inhibition, Bryostatin 1, another protein kinase C activator, induced only a modest degree of U937 growth inhibition and antagonized TPA-stimulated growth arrest. Bryostatin 1 was unable to induce this TPA-generated PU.1 binding activity. High bryostatin 1 concentrations inhibited generation of this TPA-induced band shift, These data suggest that TPA-induced growth inhibition is associated with phosphorylation of PU.1 and generation of a unique PU.1 binding activity. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:4316 / 4324
页数:9
相关论文
共 35 条
[1]  
AHNE B, 1994, J BIOL CHEM, V269, P17794
[2]  
AIHARA H, 1990, P NATL ACAD SCI USA, V87, P2294
[3]  
BLUMBERG PM, 1992, ALFRED BENZON SYMP S, V33, P273
[4]  
BOTTINGER EP, 1994, MOL CELL BIOL, V14, P2604
[5]   EFFECTS OF ACTIVATORS OF PROTEIN-KINASE C, INCLUDING BRYOSTATIN-1 AND BRYOSTATIN-2, ON THE GROWTH OF A549 HUMAN-LUNG CARCINOMA-CELLS [J].
DALE, IL ;
GESCHER, A .
INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (01) :158-163
[6]  
DAVID P, 1992, J MED CHEM, V35, P944
[7]  
DELGADO MD, 1994, ONCOGENE, V9, P1723
[8]  
DELLAQUILA ML, 1987, CANCER RES, V47, P6006
[9]  
DEVENTE J, 1995, CELL GROWTH DIFFER, V6, P371
[10]   HUMAN-LEUKEMIC MODELS OF MYELOMONOCYTIC DEVELOPMENT - A REVIEW OF THE HL-60 AND U937 CELL-LINES [J].
HARRIS, P ;
RALPH, P .
JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 37 (04) :407-422